George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,950.00
Bid: 1,946.00
Ask: 1,950.00
Change: 30.00 (1.56%)
Spread: 4.00 (0.206%)
Open: 1,922.00
High: 1,950.00
Low: 1,922.00
Prev. Close: 1,920.00
RCP Live PriceLast checked at -
RIT Capital Partners is an Investment Trust

To invest in a widely diversified, international portfolio across a range of asset classes, both quoted and unquoted; to allocate part of the portfolio to exceptional managers in order to ensure access to the best external talent available.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

18 Mar 2024 07:00

RNS Number : 1331H
RIT Capital Partners PLC
18 March 2024
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

 

18 March 2024

 

29 February 2024 Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 29 February 2024 (with debt at fair value) was 2,474p per £1 ordinary share (31 January 2024: 2,415p).

 

February 2024 Highlights

 

Global equities performed well in February, on the back of strong corporate earnings, continued US economic strength and a rebound in China. This was despite an increase in government bond yields across developed markets as stronger inflation pared back expectations of imminent rate cuts. In the US, the S&P 500 was +5.3%, with a significant portion of the gains occurring after NVIDIA published earnings. The Chinese Shenzhen index rose 9.4% in the month, driven by good data over the Chinese New Year and cuts to the key mortgage reference rate. Japanese stocks remained strong with solid corporate earnings driving the TOPIX up by 4.9% in February. Strong inflation and growth data in the US led to the US dollar rising against most currencies, with sterling ending February weaker against the dollar by -0.5%.

 

Our portfolio performed well for the month, driven by gains in our quoted equities book from our managers and individual stock selection. Uncorrelated strategies also generated healthy returns, while private investments were approximately flat for the month.

 

·

Our quoted equities book generated solid returns driven by strong earnings results from directly held stocks alongside healthy contributions from our core managers. Chinese holdings were also a solid contributor during the month.

·

Private investments held steady during the month. As of 29 February, 23% of private funds were valued at 31 December reported valuations and 76% were held at 30 September reported valuations. All private direct positions are valued at 31 December, in line with our half-yearly valuation process for these holdings.

·

Uncorrelated strategies generated healthy returns during the month, driven by positive contributions from our credit and market neutral strategies.

·

Currencies contributed positively during the month, as sterling's decline versus the US dollar led to positive translation impacts.

·

The Board continued its active buyback programme, generating a further accretive impact to the NAV per share. In the month of February, the Company repurchased approximately 0.5 million shares on behalf of shareholders.

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Numis (Joint Broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint Broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Tom Burns

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVKELFFZXLBBBB
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20242:27 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20245:22 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSNet Asset Value(s)
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20244:56 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSFinal Results
5th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:32 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20245:13 pmRNSDirectorate Change
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20241:31 pmRNSCompany Announcement
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSNet Asset Value(s)
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSNet Asset Value(s)
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20241:49 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.